Early results from a phase I study on orally administered tris(8-quinolinolato)gallium(III) (FFC11, KP46) in patients with solid tumors - A CESAR study (Central European Society for Anticancer Drug Research - EWIV)
- Author(s)
- Ralf-Dieter Hofheinz, Christian Dittrich, Michael Jakupec, Anne Drescher, Ulrich Jaehde, Margit Gneist, Nikolai Graf v. Keyserlingk, Bernhard Keppler, Andreas Hochhaus
- Organisation(s)
- Department of Inorganic Chemistry
- External organisation(s)
- Scientific Software Center, Ludwig Boltzmann Institut für Krebsforschung, Rheinische Friedrich-Wilhelms-Universität Bonn, Faustus Forschungs Compagnie GmbH
- Journal
- International Journal of Clinical Pharmacology and Therapeutics
- Volume
- 43
- Pages
- 590-591
- No. of pages
- 2
- ISSN
- 0946-1965
- Publication date
- 2005
- Peer reviewed
- Yes
- Austrian Fields of Science 2012
- 301206 Pharmacology
- Portal url
- https://ucrisportal.univie.ac.at/en/publications/7e183c0b-4349-409d-bc4d-00512f5d18f2